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Abstract
Background: The World Health Organization (WHO) revised its clinical guidelines for management of childhood
pneumonia in 2013. Significant delays have occurred during previous introductions of new guidelines into routine
clinical practice in low- and middle-income countries (LMIC). We therefore examined whether providing enhanced
audit and feedback as opposed to routine standard feedback might accelerate adoption of the new pneumonia
guidelines by clinical teams within hospitals in a low-income setting.
Methods: In this parallel group cluster randomized controlled trial, 12 hospitals were assigned to either enhanced
feedback (n = 6 hospitals) or standard feedback (n = 6 hospitals) using restricted randomization. The standard (network)
intervention delivered in both trial arms included support to improve collection and quality of patient data, provision of
mentorship and team management training for pediatricians, peer-to-peer networking (meetings and social media), and
multimodal (print, electronic) bimonthly hospital specific feedback reports on multiple indicators of evidence guideline
adherence. In addition to this network intervention, the enhanced feedback group received a monthly hospital-specific
feedback sheet targeting pneumonia indicators presented in multiple formats (graphical and text) linked to
explicit performance goals and action plans and specific email follow up from a network coordinator. At the start
of the trial, all hospitals received a standardized training on the new guidelines and printed booklets containing
pneumonia treatment protocols. The primary outcome was the proportion of children admitted with indrawing
and/or fast-breathing pneumonia who were correctly classified using new guidelines and received correct
antibiotic treatment (oral amoxicillin) in the first 24 h. The secondary outcome was the proportion of correctly
classified and treated children for whom clinicians changed treatment from oral amoxicillin to injectable
antibiotics.
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Results: The trial included 2299 childhood pneumonia admissions, 1087 within the hospitals randomized to enhanced
feedback intervention, and 1212 to standard feedback. The proportion of children who were correctly classified and
treated in the first 24 h during the entire 9-month period was 38.2% (393 out of 1030) and 38.4% (410 out of 1068) in the
enhanced feedback and standard feedback groups, respectively (odds ratio 1.11; 95% confidence interval [CI] 0.37–3.34;
P = 0.855). However, in exploratory analyses, there was evidence of an interaction between type of feedback and duration
(in months) since commencement of intervention, suggesting a difference in adoption of pneumonia policy over time in
the enhanced compared to standard feedback arm (OR = 1.25, 95% CI 1.14 to 1.36, P < 0.001).
Conclusions: Enhanced feedback comprising increased frequency, clear messaging aligned with goal setting, and
outreach from a coordinator did not lead to a significant overall effect on correct pneumonia classification and treatment
during the 9-month trial. There appeared to be a significant effect of time (representing cumulative effect of feedback
cycles) on adoption of the new policy in the enhanced feedback compared to standard feedback group. Future studies
should plan for longer follow-up periods to confirm these findings.
Trial registration: US National Institutes of Health—ClinicalTrials.gov identifier (NCT number) NCT02817971. Registered
September 28, 2016—retrospectively registered.
Introduction
Pneumonia is the second leading cause of child mortality
worldwide; 0.9 million of the 5.9 million childhood deaths
in 2015 were caused by pneumonia [1–3]. At least one
half of all global pneumonia deaths occurred in
sub-Saharan Africa [3]. The World Health Organization
(WHO) pneumonia guidelines that diagnose pneumonia
using a small number of simple clinical signs are routinely
used in sub-Saharan Africa where resources for laboratory
and radiologic diagnosis of pneumonia are limited [4].
Prior to 2013, WHO guidelines recognized three pneumo-
nia severity classifications: pneumonia, severe pneumonia,
and very severe pneumonia [5, 6]. According to previous
guidelines, a child with a cough or difficult breathing was
diagnosed with pneumonia if they developed fast breath-
ing. Severe pneumonia was defined by lower chest wall
indrawing in a child with cough or difficult breathing
while a diagnosis of very severe pneumonia was made in
children who developed any danger sign (inability to
drink/breastfeed, altered consciousness, grunting, central
cyanosis, hypoxia) in the presence of cough or difficult
breathing. The severity of pneumonia guides subsequent
antibiotic treatment. Emerging research, however, chal-
lenged this original guidance [5, 7]. First, studies suggested
equivalence between injectable penicillin and oral amoxi-
cillin for the treatment of pneumonia characterized by
indrawing but no danger signs [8]. Second, studies
suggested that the population of children with pneumonia
and indrawing but no danger signs for whom recommen-
dations suggested inpatient care could be successfully
treated as outpatients [9].
The WHO responded to this new evidence in 2013 by
making the first major revisions to childhood pneumonia
guidelines in many years [4, 10]. These revisions aimed to
(1) simplify the classification of childhood pneumonia
severity to two categories instead of three and (2) switch
treatment from injectable penicillin to oral amoxicillin for
children aged 2–59months with pneumonia characterized
by indrawing but no danger signs (hereafter referred to as
indrawing pneumonia). The treatment change harmonized
the treatment for indrawing pneumonia with that for pneu-
monia defined only by fast breathing (without either
indrawing or any danger signs). The 2015 results of a Ken-
yan trial also suggesting equivalence of injectable penicillin
and oral amoxicillin (conducted on hospitalized patients)
prompted a change in Kenyan pneumonia guidelines to
align with the new WHO guidance in 2016 [11].
Progress in translating policy changes such as these
for pneumonia into routine clinical practice is slow in
sub-Saharan Africa [12], even in cases where clear guid-
ance exists [13]. This slow progress is particularly evi-
dent for policies that require changes in well-established
clinical behaviors [14]. For example, in Kenya, reducing
the unnecessary use of cough medicines as co-treatment
of pneumonia has taken many years [15], while changing
first-line treatment for inpatient severe malaria has taken
several years [16]. The advent of new pneumonia guide-
lines in Kenya therefore provided an opportunity to
study implementation strategies that might accelerate
adoption of the new guidelines.
Audit of hospital care is widely used as a strategy for im-
proving quality of care. Clinical audit involves measuring
clinical teams’ performance in providing care [17–19]. The
effect of audit is enhanced when it is coupled with feedback
where agents (e.g., peers or supervisors) provide informa-
tion regarding individual health worker or clinical teams’
performance [17, 18]. The suggested mechanism through
which audit and feedback improves performance in hospi-
tals is by identifying and reducing the discrepancy between
current and desired performance [20]. Interventions that
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make better use of audit and feedback provide a possible
strategy for promoting desired clinical performance follow-
ing changes in health policies. We therefore designed a
study to compare the effect of alternative audit and feed-
back strategies delivered concurrently with dissemination
of the new policy on the uptake of policy recommenda-
tions. Our trial aimed to test whether enhancing the fre-
quency and format of feedback and incorporating goal
setting and action planning could result in more rapid
adoption of the new policy of using oral amoxicillin for
indrawing pneumonia. This randomized trial directly ad-
dresses a need expressed in a systematic review that in-
cluded 140 studies that “future studies of audit and
feedback should directly compare different ways of provid-
ing feedback” [21]. Addressing the question of how best to
promote policy adoption is also important as failure to im-
plement evidence-based policies in routine practice under-
mines the whole research enterprise.
Methods
Study design
A pragmatic parallel group cluster randomized trial was
conducted over a 9-month period in 12 county hospitals
providing first level inpatient referral care in Kenya that are
part of a clinical information network (CIN) [22, 23]. The
hospital was the unit of randomization. The cluster design
was selected because inpatient pediatric care is organized
around multidisciplinary teams composed of doctors and
nurses among other health workers and providing team
level feedback is logistically easier for health systems.
Secondly, it is much more effective to deliver the interven-
tion at hospital level rather than individual health worker
level in hospitals with rapid staff turnover where the
individual, junior front-line clinicians change every 3
months. This is the group of clinicians who are expected to
adhere to the pneumonia guidelines.
Study participants
The 14 hospitals in CIN were selected in consultation with
the Ministry of Health from 12 out of the 47 counties in
Kenya. All these hospitals were public government-owned
hospitals and were estimated to admit at least 1000 children
per year and located in one of the main malaria ecological
zones in Kenya (either high or low to very low malaria
transmission). For the trial, 12 of the initial 14 hospitals,
one from each county, were selected for inclusion. The hos-
pitals that were excluded from the trial were a small facility
(less than 1000 admissions per year) that is staffed by clin-
ical officers (physician assistants) and not resident physi-
cians or pediatricians as in the other 13 CIN hospitals. The
second facility was excluded from the trial because it had
existing formal linkages with other research and academic
institutions that might influence the intervention effect.
Individual case records were identified for post-dis-
charge medical record review in each participating hos-
pital if the admissions were aged between 2 and 59
months and had a provider clinical diagnosis of pneu-
monia regardless of signs or symptoms. We excluded ad-
missions with cough persisting more than 2 weeks or
co-morbid conditions for which there are specifically
recommended antibiotic treatments in Kenyan guide-
lines including meningitis, HIV, severe malnutrition,
severe malaria (spanning cerebral malaria and severe
malaria anemia), surgical conditions, and sepsis [24].
Interventions
The trial had two arms, and each trial arm received one of
the two intervention strategies implemented between
March 10, 2016, and December 4, 2016. The first interven-
tion (referred to as enhanced feedback) involved an audit
on indicators of pneumonia care with feedback delivered
every month, using a specific pneumonia feedback sheet
provided in both graphical and text-based formats. We
incorporated explicit performance goals for each audit and
feedback cycle with accompanying action plans for relevant
indicators. The network coordinator (a senior pediatrician)
sent emails to the local pediatrician encouraging them to
read and act on the received feedback. The enhanced feed-
back intervention was designed drawing on Feedback Inter-
vention Theory [20], the modifications to this theory
suggested by Hysong and colleagues [18, 19], and a system-
atic review that suggests which attributes of feedback may
promote its effectiveness [21].
The second intervention (referred to as standard feed-
back) was audit and feedback of general pediatric care
delivered less frequently (bimonthly), using a single
format of comprehensive performance reports for gen-
eral indicators of pediatric care spanning five major con-
ditions including pneumonia and described in more
detail elsewhere [25]. Additionally, both trial arms re-
ceived a half-day training delivered to the clinical and
nursing teams on the new pneumonia guidelines at the
start of the trial. Clinicians in all hospitals were also sup-
plied with updated protocol booklets that contained in-
formation on the new pneumonia guidance including
specific pneumonia algorithms articulating the key clin-
ical signs and how these are to be used in classification
together with dosage tables for oral amoxicillin. Finally,
all hospitals in the trial received continued network
support, described in detail in the next section under
intervention context.
Intervention context
The Kenyan clinical information network has been in
operation since late 2013 and has adopted a range of ap-
proaches to understand and improve hospital care
(Table 1). A full description of its components, activities,
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and theoretical underpinnings is presented elsewhere [26].
In brief, CIN components and activities comprise (1) ini-
tial mentorship and basic training on team management
provided to hospitals’ pediatricians in 2014 and early 2015
to promote their engagement in service improvement, (2)
data collection that supports the provision of hospital-spe-
cific reports on quality of documentation and adherence
to multiple guidelines (spanning recording of key clinical
signs, appropriate use of basic diagnostic tests and assess-
ment and treatment of malaria, pneumonia, diarrhea &
dehydration, meningitis, and severe acute malnutrition),
and (3) peer to peer networking through twice yearly
meetings and a simple WhatsApp group. Hospital reports
are sent as printed documents and by email to the
pediatrician, the lead pediatric nurse and the medical
superintendent in each hospital; the pediatrician is
expected to provide feedback to frontline pediatric care
providers on their hospital’s performance. Prior to the
trial, over the period 2014 to 2015, all hospitals had
received nine comprehensive performance reports. During
the trial period, all 12 hospitals continued to receive wider
network support (captured in items b and c above) includ-
ing the comprehensive feedback reports sent every 2
months. From the start of the trial these standard reports
contained, among much other information, feedback in
the form of tables of indicators of hospitals’ correct per-
formance in documentation of pneumonia clinical signs,
pneumonia classification, and pneumonia treatment
reflecting adherence to the new guidelines.
Revised pneumonia policy
WHO and Kenyan guidelines use simple clinical signs to
identify children with pneumonia and then assign a classi-
fication for severity of pneumonia in settings with little or
no access to diagnostic technology. The new guidelines
recommend which among three possible case management
actions is applicable (after appropriate treatment for
wheeze where indicated): (1) symptomatic treatment for a
simple upper respiratory tract infection without giving an-
tibiotics, (2) treatment with oral Amoxicillin for fast
breathing or indrawing but no danger signs, (3) providing
supportive care and combination injectable antibiotic treat-
ment where there are danger signs.
This trial targeted the second case management action,
i.e., treatment with oral Amoxicillin for fast breathing or
indrawing but no danger signs. The dispersible formulation
of oral Amoxicillin was supplied to all hospitals during the
entire trial period (courtesy of UNICEF Kenya). This con-
tinuous and reliable supply ensured that differences in drug
Table 1 Key components of the multifaceted intervention to improve adoption of new pneumonia policy
Intervention Description Treatment arm
involved
Network strategy o Sensitization of hospital pediatric care teams on quality healthcare service
by coordinating team
o Initiative to improve quality of pediatric data through providing minimal ICT
infrastructure (desktop computer), introduction of standardized pediatric admission
record form, and recruitment of data clerk at each hospital
o Establishment of clinical information network bringing together Ministry of Health,
pediatric professional organization, hospital team leaders, and senior peers from a
local University and a research organization
o External facilitation of quality improvement efforts by network coordinating team
through 6 monthly face-to-face network meetings and communication with pediatricians
(via phone, email, social media) and a total of 2 or 3 hospital visits in 2014 and early 2015
Both intervention
and control
Standard audit
and feedback
o Developing and implementing tools for monitoring indicators of quality of general
pediatric care
o Two to three-monthly feedback reports of performance assessed against national
guidelines for
pediatric care
o Each hospital’s performance compared to its own performance in the preceding period
and also compared anonymously to other network hospitals
o General encouragement offered to improve all aspects of care by coordinator to team
leaders by 2-monthly phone/email communication
Both intervention
and control
Enhanced audit
and feedback
o Definition of goals for adoption of new pneumonia* policy
o Monthly feedback in text of:
▪Hospital performance in comparison with goals for indicators of correct pneumonia
classification and treatment as contained in new policy
▪Hospital performance in comparison with anonymized performance information of
other hospitals
o Graphical representation of each hospital’s performance trend by month from the start
of the intervention
o Specific follow up on pneumonia indicator performance by coordinator with team leaders
by monthly phone/email communication
Intervention only
*Specific goals included attaining at least 80% compliance with classification and treatment for childhood pneumonia admissions
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supplies did not impact on implementation of the interven-
tion or the resulting intervention effect.
Outcomes
The primary outcome was the proportion of all admitted
patients with pneumonia characterized by fast breathing
or chest indrawing who were both correctly classified and
treated in the first 24 h. For this outcome, prescription of
correct treatment (i.e., oral amoxicillin for pneumonia)
was contingent on correct classification of pneumonia se-
verity. Based on the clinical signs documented in the
medical record during admission, we determined whether
a child had pneumonia defined by chest indrawing or fast
breathing (> 50 breaths per minute in neonates and > 40
breaths per minute in children aged 1 to 59months). We
then checked the records to establish which of the two
alternative classifications—pneumonia or severe pneumo-
nia—recommended in the new guidelines was assigned by
the clinician. Children correctly classified as (indrawing)
pneumonia and with clinical signs consistent with this
classification who were also prescribed oral amoxicillin
were regarded as meeting the primary outcome definition.
Those who had incorrect classification (severe pneumonia
according to new guidelines or other classification not
contained in new guidelines) were considered not to have
met the primary outcome definition irrespective of
whether they were prescribed oral amoxicillin. Similarly,
children with correctly classified (indrawing) pneumonia
who were not prescribed oral amoxicillin did not meet the
primary outcome definition.
We also explored a secondary descriptive outcome,
the proportion of correctly classified and treated chil-
dren with (indrawing) pneumonia for whom clinicians
changed treatment from oral amoxicillin to injectable
antibiotics. The new guidelines recommend a switch to
injectable antibiotics in the following cases: first, at any
time when a child progresses from (indrawing) pneumo-
nia to severe pneumonia during the course of oral treat-
ment; second, at 48 h in case (indrawing) pneumonia
does show improvement in at least one sign (respiratory
rate, severity of indrawing, fever or ability to drink); and
third, during day 5 of treatment if at least three of the
following criteria are present: fever; respiratory rate
above 60 per minute; cyanosis; persistent chest indraw-
ing or worsening chest x-ray.
Sample size
We estimated that at least 680 patients with (indrawing)
pneumonia would be required per arm to evaluate the pri-
mary outcome and that such numbers would be achievable
in a period of 9months after trial commencement with six
hospitals per arm. We assumed an average cluster size of
113 patients and an ICC of 0.2 (corresponding to a VIF of
15.8 derived from patterns of pneumonia classification and
treatment in CIN hospitals prior to trial commencement)
and Type I error of 5%. This provided 90% power to detect
a two-fold increase in the odds of correct (indrawing)
pneumonia classification and treatment assuming a 30%
compliance with the guideline-recommended pneumonia
classification and treatment in the standard feedback group.
Randomization
The trial statistician performed restricted randomization of
12 hospitals that involved randomly selecting a single alloca-
tion of clusters to treatment arms from a subset of all the
possible allocations of six hospitals per arm that retained bal-
ance on key covariates. We aimed to ensure relative balance
was achieved between treatment arms in terms of geographic
location as a proxy for malaria prevalence (2:3 or 3:2 split of
the five hospitals located in western Kenya) and monthly
pneumonia admissions (3:4 or 4:3 split of the seven hospitals
admitting < 30 pneumonia admissions per month). Details of
the randomization have been published [27], but in brief
there were 924 possible allocations of 12 clusters into two
groups of which 536 allocations met the defined balancing
criteria, and one of these 536 allocations was randomly
selected by the statistician using computer-generated ran-
dom numbers (R software 3.3.3) [28].
Data collection
The data collection and management procedures have
been described in detail elsewhere [23, 29]. In brief, data
were entered into an electronic database from inpatient
paper-based medical records at the point of discharge. A
data clerk at each hospital was trained on abstracting clin-
ical data from medical records using standard operating
procedures. These clerks who were blinded to group allo-
cation documented patient biodata, admission clinical fea-
tures and history of illness, initial and subsequent
antibiotic treatment, and discharge outcomes. The clerk
synchronized data to a centralized server hosted at the
KEMRI-Wellcome Research Programme on a daily basis
after running error checking scripts and reviewing any
entries that had queries (out of range values, plausibility
checks). A second round of error checking was done after
synchronization in the main servers and any further quer-
ies communicated to the clerks by telephone and resolved
where possible. Lastly, three monthly external data quality
assurance (DQA) were conducted by a research team that
visited the hospital and reentered a random selection of
approximately 10% of observations entered in the data-
base during the period preceding the DQA [27].
Data analysis
The study protocol containing the pre-specified analysis
plan has been published [27]. For the analysis of the pri-
mary outcome, we have fitted a hierarchical logistic
regression model. The dependent variable was an
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indicator of whether or not the child admitted with
(indrawing) pneumonia was correctly classified and
treated according to new guidelines (coded 1 for chil-
dren who were correctly classified and treated, otherwise
the indicator was coded 0). We hypothesized that a
gradual and cumulative change might occur in adher-
ence to the new guideline with each successive feedback
cycle. We therefore included independent variables
representing trial arm (standard versus enhanced feed-
back), time of patient admission to hospital in relation
to duration of intervention (a variable indicating time in
completed months—between 1 and 9—calculated from
the start of the study to the admission date), and an inter-
action between trial arm and time (trial arm × time). The
interaction term was used to estimate the difference in the
gradient of slopes for intervention and control arms.
Therefore, term represented the difference in the change
in primary outcome over the 9-month follow-up between
the two groups [30]. We tested the assumption that for
both groups, the log odds of correct treatment and classi-
fication in the logistic model were a linear function of time
through modeling nonlinear relationships. We used
random intercept models to account for variation in
performance between hospitals in the first follow-up
month before any feedback had occurred. To adjust for
the small number of clusters (n = 12) and large variation
of cluster sizes that are associated with an inflated Type I
error, we estimated mixed logistic models using adaptive
Gaussian-Hermite approximations to the likelihood. This
approach yields less biased estimates with few clusters
compared to Laplace approximation or penalized
quasi-likelihood [31–33]. Bootstrapping was used to ob-
tain the reported confidence intervals. Adjustment for
case mix between hospitals was done by including
patient-level factors in the model, namely sex and age. At
the hospital level, we included indicator variables to show
whether a hospital was located in a malaria-endemic area,
and a separate variable indicating whether it was in a rural
or urban setting. We performed a descriptive analysis of
the secondary outcome of antibiotic switch from oral to
injectable antibiotics to explore clinically suspected treat-
ment failure as a measure of perceived safety of oral
amoxicillin. This study is reported as per the Consolidated
Standards of Reporting Trials (CONSORT) for cluster
trials guidelines (Additional file 1: Table S1).
Multiple imputation
During exploratory analysis, we established that the pro-
portion of missing data for individual clinical sign variables
relevant for classifying pneumonia severity was between 2
and 15%. We therefore used multiple imputations to han-
dle missing data and allow classification of all pneumonia
patients. We used Bayesian bootstrap predictive mean
matching to impute missing data 50 times. The imputed
variables included numeric covariates (e.g., age) and cat-
egorical variables (clinical signs). After imputation, diag-
nostic checks were conducted to compare distribution of
imputed and observed data. Each imputed dataset was
analyzed and the estimates combined using Rubin’s rules
[34]. Sensitivity analyses were conducted to assess robust-
ness of inference to possible departure from missing at
random assumptions.
Results
Delivery of the enhanced feedback intervention
The feedback intervention was successfully delivered to
all the 12 hospitals that had been randomly assigned to
enhanced or standard intervention (Fig. 1). All hospitals
followed the planned timing and frequency of feedback
provision. Nine months after the start of the study,
eight rounds of monthly pneumonia-specific feedback
had been delivered in each intervention hospital and
four rounds of bimonthly general feedback had been
provided to hospitals in both trial arms. Enhanced feed-
back reports were dispatched on the same day to all
intervention hospitals throughout the study period as
per the original plan, and general feedback reports were
sent out to all hospitals within 2 days of the date on
which they were due. None of the hospitals withdrew
from the study.
Trial participants
There were a total of 2299 eligible (indrawing) pneumo-
nia admissions to all 12 participating hospitals during
the trial period. Of these patients, 1087 were from hospi-
tals assigned to enhanced feedback and 1212 from
hospitals assigned to standard feedback. The median
number of pneumonia admissions to hospitals in the
enhanced feedback trial arm was 166 (range 47 to 383)
and that of admissions to the standard feedback arm was
202 (range 89 to 329). Comorbid illnesses were common
(66.5%) in admissions even after exclusion of patients
with HIV, severe malnutrition, meningitis, and severe
malaria for whom different antibiotic regimens are
recommended (Table 2).
The baseline characteristics of hospitals and pneumo-
nia admissions to the hospitals were similar between
trial arms (Table 2). The median age of children admit-
ted with pneumonia was 13 months (interquartile range
8–24 months). One hundred and ninety-five out of all
pneumonia admissions (8.5%) had a wheeze during ad-
mission which is a guideline criterion for considering a
possible diagnosis of asthma. Treatment with broncho-
dilators is recommended in children with wheeze and
the initial bronchodilator treatment could lead to a
revision of pneumonia classification. Out of the admis-
sions with information on whether they had received
prereferral treatment at a separate health facility prior
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to admission in hospitals participating in the study, 14.9%
(280 out of 1884) had documentation showing that they
were referred from other health facilities to the admitting
hospital. Discharge outcome following hospitalization for
(indrawing) pneumonia treatment was also similar across
the two trial groups. The median length of stay was 3 days
(IQR 1–5 days). The overall mortality among pneumonia
admissions was 2.6% (59 out of 2299) with group-specific
mortality of 2.0% (22 out of 1087) and 3.1% (37 out of 1212)
in the enhanced and standard feedback groups, respectively.
Primary outcome
We assessed a contingent primary outcome in which
correct treatment was determined in the group of children
who had correct (indrawing) pneumonia classification.
During the 9-month trial period, 615 out of 1087 (56.6%)
and 742 out of 1212 (61.2%) pneumonia admissions were
correctly classified in the enhanced and standard feedback
groups, respectively. Data on antibiotic prescriptions within
24 h of admission were not available for 57 (5.2%) and 144
(11.9%) children in the enhanced and standard feedback trial
arms, respectively (Fig. 1). Therefore, the primary outcome
of correct pneumonia classification and treatment could not
be determined in these admissions without antibiotic pre-
scriptions resulting in the assessment of primary outcome in
1030 children in the enhanced feedback group and 1068
children in the standard feedback group. For the primary
outcome, 393 out of 1030 children in the enhanced feedback
group (38.2%) and 410 out of 1068 children in the standard
feedback group (38.4%) were correctly classified and treated
Fig. 1 Flow diagram of progress of clusters and individuals through the cluster RCT
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using oral amoxicillin during the entire 9-month period
(odds ratio 1.11, 95% CI 0.37–3.34; P= 0.855). The children
with the primary outcome represented 63.9% (393/615) and
55.3% (410/742) of correctly classified children in enhanced
and standard feedback groups, respectively.
The enhanced feedback hospitals had poorer classifica-
tion and treatment practices at baseline OR 0.54, 95% CI
0.19 to 1.68 (Table 3). On exploring monthly performance
of correct pneumonia classification and treatment after
each round of enhanced feedback, there was an improve-
ment in the enhanced feedback group while performance
declined in the standard feedback arm (Fig. 2). The decline
after month 7 in standard feedback arm was attributable
to consistently poor performance in four out of the six fa-
cilities (Additional file 2: Figure S1). The coefficient for
the interaction term between intervention group and time
(in months) provided evidence of a significant difference
in the slope of change with time between the trial arms
OR = 1.25, 95% CI 1.14 to 1.36 (Table 3). The odds of cor-
rect practices increased by 19% per month in the interven-
tion arm while the estimated odds declined by 5% per
month in the control group.
The predicted odds of correct classification and treat-
ment of (indrawing) pneumonia admissions did not
Table 2 Characteristics of hospitals and patients participating in the CIN audit and feedback intervention trial
Characteristics Enhanced
feedback
Standard
feedback
Total
Cluster level
No. of hospitals, n/N 6/6 6/6 12/12
No. of hospitals with > 1 pediatrician*, n/N 2/6 1/6 3/12
No. of hospitals in malaria-endemic regions, n/N 3/6 2/6 5/12
No. of hospitals with > 40 pediatric beds, n/N 2/6 2/6 4/12
Individual level
Pneumonia admissions 1087 1212 2299
Median age in months, (IQR) 12 (7–17) 14 (8–18) 13 (8–24)
Males, n/N (%) 604/1086 (55.6%) 661/1200 (55.1%) 1265/2286 (55.3%)
Duration of illness in days, median (IQR) 3 (2–5) 3 (2–5) 3 (2–5)
Referred to hospital, n/N (%) 101/860 (11.7%) 179/724 (17.4%) 280/1884 (14.9%)
Clinical findings during admission documented
using a structured admission record form**, n/N (%)
1069/1083 (98.7%) 1199/1211 (99%) 2268/2294 (98.9%)
Wheezing present during admission, n/N (%) 83/1084 (7.7%) 112/1203 (9.3%) 195/2287(8.5%)
Comorbid diagnosis present at admission***, n/N (%) 692/1027 (63.7%) 827/1212 (68.2%) 1519/2299(66.1%)
Mid-upper-arm-circumference, median (IQR) 14 (13–15) 14 (13–15) 14(13–15)
Length of hospital stay, median (IQR) 2 (1–5) 3 (2–6) 3 (1–5)
Died, n/N (%) 22/1087 (2.0%) 37/1212 (3.1%) 59/2299 (2.6%)
*All remaining hospitals had a single pediatrician
**Structured admission forms were introduced within network hospitals to improve quality of documentation of features of illness, investigations
and management
***Any comorbid illness not excluded in trial exclusion criteria, e.g., dehydration
Table 3 Effect of audit and feedback intervention on correct classification and treatment of childhood pneumonia admissions
in CIN hospitals
Primary model estimates Multiple imputation model
(sensitivity analysis)
Adjusted OR (95% CI) P value Adjusted OR (95% CI)
Enhanced audit and feedback intervention 0.54 (0.19, 1.68) 0.270 0.52 (0.18, 1.53)
Time (in months) 0.95 (0.89, 1.01) 0.090 0.95 (0.90, 1.01)
Time × feedback intervention 1.25 (1.14, 1.36) < 0.001 1.24 (1.14, 1.35)
Age in months 1.00 (0.99, 1.01) 0.749 1.00 (0.99, 1.01)
Male 1.07 (0.87, 1.35) 0.496 1.06 (0.87, 1.29)
Malaria-endemic area 0.6 (0.22, 1.4) 0.338 0.61 (0.22, 1.65)
Hospital located in urban area 0.41 (0.14, 1.32) 0.142 0.42 (0.13, 1.28)
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differ significantly between the trial arms during the ini-
tial months of the trial (Fig. 3). However, performance in
classifying and treating childhood pneumonia was better
in the enhanced feedback arm by the ninth month (OR
3.6, 95% CI 1.17 to 11.1).
The sensitivity analysis conducted on multiply-im-
puted data is presented in Table 3. Findings of the ana-
lysis were consistent with those of the primary analysis
(Additional file 3).
Secondary outcome
There were 91 patients who had their antibiotics switched
from oral to injectable antibiotics among the correctly clas-
sified and treated children yielding an overall prevalence of
12.7% (95% CI 10.4 to 15.4). Forty-three out of 340 (12.6%,
95% CI 9 to 16.7) patients in the enhanced feedback group
and 48 out of 375 (12.8%, 95% CI 9.6 to 16.6) patients in
the standard feedback group who were initially correctly
classified and treated with oral amoxicillin had a treatment
switch to injectable antibiotics.
Discussion
We assessed whether providing enhanced feedback to
clinical teams is effective in improving the uptake of new
guidelines for treatment of (indrawing) pneumonia in hos-
pitals. In this trial, we did not show an overall difference in
correct classification and treatment of childhood pneumo-
nia. Approximately 40% of pneumonia admissions in each
of the two trial arms were correctly managed according to
the new guidelines over the entire 9-month trial period. In
literature, the evidence for the effect of multifaceted prac-
tice change interventions remains mixed [35, 36]; although,
we have previously shown benefits in the Kenyan hospital
setting [37]. Observational analyses conducted in participat-
ing hospitals prior to the onset of this trial also show the
network intervention has improved clinical documentation
[29], for example, ascertainment of HIV status and adop-
tion of MUAC measurement [38].
The standard feedback provided within the network is
hospital-specific with peer comparison data, is provided
regularly, using multiple modes of delivery (paper, elec-
tronic, text and graphical presentation), but includes
pneumonia policy adherence indicators within a com-
prehensive performance report spanning multiple
common conditions [27]. This standard feedback had
been provided for over 2 years to each hospital prior to
the trial. It is accompanied by network activities aimed
at promoting clinical leadership through mentorship
Fig. 2 Correct classification and treatment of childhood pneumonia admissions according to duration of intervention and type of
feedback intervention
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linked to twice yearly face-to-face network meetings,
peer to peer support through a WhatsApp group, and
expert outreach by a senior clinical coordinator [17, 26].
The enhancements to standard feedback we tested
were use of a specific feedback form, increased
frequency of feedback, use of goal setting for target indi-
cators linked to suggested actions for improvement, and
follow-up of feedback by a senior pediatrician. Such en-
hancements were selected on the basis of theory and in-
ferences drawn from prior systematic reviews on aspects
of feedback that show most promise [17, 18, 20]. We hy-
pothesized that these elements when combined would
improve the self-efficacy and motivation to promote pol-
icy adoption among the lead pediatricians particularly
and their junior team members who actually provide
admission care.
The trial, conducted in a resource-constrained health-
care setting, showed that the overall adoption of the new
policy after initial training, guideline dissemination, and in
the context of the network activities and feedback
approaches we have described was moderate at approxi-
mately 40%. Failure to use recorded signs to direct treat-
ment (misclassification) rather than inappropriate
treatment once correctly classified accounted for most
cases of incorrect performance. Initial training and dis-
semination of guidelines appeared to result in modest
(and variable) adoption of the new policy. Subsequently,
there was declining performance in hospitals receiving
standard feedback (from a higher baseline) and increasing
performance with enhanced feedback. This is consistent
with the possibility that clinicians in the standard feedback
arm slowly revert to prior behavior [39], whereas we
speculate that enhanced feedback aimed particularly at
the clinical team leader sustained and promoted guideline
adoption among junior team members possibly through
better reinforcement practices.
The decline in performance in the control arm may also
be linked to staff rotations that occur frequently in Kenyan
hospitals. Frontline staff who admit patients to district hos-
pitals are typically intern clinicians in their first year of
experiential training in countries like Kenya. Such staff typ-
ically rotate every 3months and two such rotations oc-
curred during this trial across both trial arms. The decline
in performance in standard feedback hospitals may there-
fore have resulted in care increasingly being provided by
clinicians who had not had specific training on the guide-
lines. Efforts were made to make sure these new clinicians
had copies of guideline booklets. In the enhanced feedback
hospitals, we suggest the pediatricians leading practice
made a greater effort to support guideline adoption provid-
ing some insulation against staff turnover; although, we
were unable to collect data on the actual practices of
pediatric team leaders in intervention and control hospitals
that might support this proposition. However, this sugges-
tion is consistent with previous work in similar settings in
which we observed that new practices became slowly em-
bedded in hospital routines with long-term feedback des-
pite considerable staff turnover [37].
Fig. 3 Odds ratios for correctly classifying and treating pneumonia in enhanced compared to standard feedback hospitals. At each time point
(months 1 to 9), we estimated the odds of correct classification and treatment for patients admitted during the immediately preceding one-
month period that coincided with dissemination of the monthly enhanced feedback reports in the intervention arm. The odds ratios (95% CI) are
then plotted at these monthly time points and show the predicted odds of correct classification and treatment of pneumonia admissions in the
enhanced feedback trial arm compared to the standard feedback arm (adjusted for patient and hospital level factors)
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The enhanced feedback intervention may have
achieved more sustained adoption of the policy com-
pared to standard feedback, but our findings suggest that
there is still considerable scope for improving policy
adoption requiring additional interventions. For ex-
ample, neither the enhanced nor the standard feedback
arm achieved the target performance of 80% compliance
with correct classification and treatment for pneumonia.
The failure to attain this goal could be explained by the
level of goal difficulty. Greater success was achieved with
classification of pneumonia severity using simple clinical
signs, but performance declined when we examined the
composite outcome with an additional requirement of
prescribing appropriate treatment for the assigned pneu-
monia classification. Thus, the overall performance for
correct classification in the trial ranged between 64%
and 74% in the trial arms, but up to 32% of children in
the control sites did not receive oral amoxicillin despite
having been correctly classified (indrawing) pneumonia.
There remains a need to investigate why clinicians have
trouble adhering to treatment guidelines once they have
correctly classified a child. A possible explanation is a
lack of belief among clinicians in oral treatment or
monotherapy hence the tendency to assign a more se-
vere pneumonia classification to warrant use of inject-
able or broader spectrum antibiotics [40]. A useful
additional finding from our study was that treatment
failure among children given oral amoxicillin was similar
to that of children who were started on injectable peni-
cillin, a finding supporting the results of previous ran-
domized trials [9, 11]. Demonstrating that almost nine
out of ten children quickly improve on oral treatment
may help provide some assurance to clinicians that oral
treatment for (indrawing) pneumonia confers no more
risk than injectable treatment, knowledge that may facili-
tate wider policy adoption. However, non-trivial mortal-
ity in this group of children in hospital does suggest the
need for additional research factors that would help cli-
nicians assess risk and additional on interventions to im-
prove outcomes.
The optimal duration of time for providing feedback
interventions to promote policy adoption is unclear [21],
and it is possible that greater improvements would have
occurred if the intervention was implemented for a lon-
ger period. This is suggested by the apparent benefits of
enhanced feedback seen in the final months of the inter-
vention period. There is a need for studies to determine
how long it would take to embed new policies in prac-
tice. Future feedback intervention designs could also
target individual clinicians as an additional approach to
promote policy uptake especially during health provider
rotations that occurred frequently in our trial. This
could be done using phone text messaging which had
been implemented successfully in previous randomized
trials [41]; although, logistically, such interventions
would be much harder to sustain at scale.
At present there is still limited work on how to imple-
ment new national policies at scale in LMIC. The failure
to monitor implementation means much research evi-
dence is not effectively translating to health benefits. We
have shown that modest investments in information sys-
tems may support improvements [16, 23, 25, 29], and
could support audit and feedback interventions. Invest-
ments in information systems within the field of adult
and pediatric HIV care have shown that it is feasible to
use such systems to improve antiretroviral therapy
guideline adherence at scale under routine care condi-
tions in LMICs [42, 43]. We argue that greater attention
needs to be paid to improving information systems not
just aimed at centralized national reporting but to enable
monitoring and develop feedback interventions that pro-
mote adoption of effective interventions as part of wider
efforts to reduce newborn and child mortality [44].
Strengths
The cluster RCT design and methodologic rigor applied in
the evaluation are a strength. Although we could
randomize only 12 hospitals, we performed restricted
randomization to minimize baseline imbalance in charac-
teristics between trial arms (a major challenge in cluster
trials). We also used random intercept multilevel models
to account for any residual imbalances in performance at
baseline therefore improving our ability to attribute any ef-
fects to intervention. To our knowledge, this is among the
first studies conducted in low- and middle-income African
countries to examine different approaches to providing
feedback at hospital level while exploring characteristics of
feedback that can optimize effectiveness. Our study was
based on a theory-driven intervention that responded to
current priority research areas within this field [17] and
was conducted within a network with good quality data.
Limitations
There are several limitations of the current study. First,
neither the trial investigators nor the participants were
blinded. However, the clerks who were responsible for
data collection were unaware of the hospital allocation
to intervention reducing the potential of differential
documentation of physical examination findings, pneu-
monia severity classification, and treatment during data
abstraction. Separately, contamination of intervention
could have occurred through peer to peer interactions
during the single face-to-face network meeting held
while this trial was in progress and possibly through dis-
cussions on a social media platform (WhatsApp). We
did not determine the extent of contamination but the
decline of performance in the control arm suggests that
this potential contamination was minimal and did not
Ayieko et al. Implementation Science           (2019) 14:20 Page 11 of 14
strongly influence the intervention effect. Separately, we
did not study a random sample of hospitals and the
findings in this study are most directly generalizable to
county hospitals that provide primary referral inpatient
care and that are also in receipt of some form of routine
performance feedback (a situation that is rare in LMIC).
Despite this limitation, we believe these findings are
relevant to LMIC hospitals particularly as electronic
medical records (EMR) are rapidly being introduced in
many countries. Our findings further suggest that the
rollout of EMRs should be accompanied by careful plan-
ning to incorporate appropriate data collection and en-
able further testing of audit and feedback. A further
limitation of this trial is that due to reliance on informa-
tion obtained from medical records at discharge, it is
difficult to determine whether the intervention improved
the actual care received, documented practice, or both.
Conclusions
We have demonstrated that enhanced feedback as op-
posed to standard feedback delivered as components of
a multifaceted network intervention did not result in
improvements in the overall proportion of children
managed in accordance with the new guidelines. How-
ever, providing enhanced feedback was associated with
improving compliance over time. Findings suggest spe-
cific components of feedback including its frequency,
links between goal setting and targeted action plans, and
reinforcement by a senior professional may promote
slow adoption of policy recommendations. Overall, pol-
icy makers, researchers, and implementers should pay
more attention to utilizing and testing evidence-based
strategies including audit and enhanced feedback to
achieve policy adoption in low and middle income coun-
tries if the benefits of research investments and new in-
terventions are to be realized.
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